Zai Lab Points up as Chinese Gov't Okays Tumor Treatment
ZAI Lab announces the China National Medical Products Administration (NMPA) has granted Innovative Medical Device Designation for Tumor Treating Fields ($35.69, 0.00)
StreetAccount Summary - US Pre-market trading update
StreetAccount Summary - US Pre-market trading
StreetAccount Summary - Trading higher/lower: Asia mid-morning
StreetAccount Summary - Trading higher/lower: Hong Kong mid-morning
StreetAccount Sector Summary - Healthcare Post-Market
StreetAccount Sector Summary - Healthcare Pre-Market
Powered by FactSet Research Systems Inc.